MS News & Perspectives

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how the FDA has approved Cortrophin Gel, an ACTH gel first introduced in the 1950s, for treating acute flare-ups in multiple sclerosis (MS); and reads “An Epstein-Barr Virus Primer for MS Patients”, a column by Ed Tobias. =================================== Are you interested in learning more about multiple sclerosis...

In 2007, Tyler Campbell, son of Hall of Fame legend, Earl Campbell, was diagnosed with Multiple Sclerosis while playing football at San Diego State University. He continued to play football while keeping his diagnosis a secret. Unfortunately, shortly after his NFL Pro Day at San Diego, Tyler experienced a major setback that landed him in the hospital and in a wheelchair, unable to walk. After this...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how new preclinical data continues to support the potential of Cyxone’s investigational plant-derived peptide T20K for the treatment of multiple sclerosis (MS). Price also reads the column by Jamie Hughes, A Life in Letters, “When Is a Wall Not Just a Wall?”. =================================== Are you interested in...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a population-based study tied infectious mononucleosis (EBV) in childhood or adolescence to a roughly 2-to-3 times greater MS risk as adult.  Also, Price Wooldridge, reads the column by John Connor, Fall Down, Get Up Again, “An Interview With My Primary Carer”. =================================== Are you interest...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how mice kept for two weeks at 10 C (50 F) showed lesser MS-like symptoms and inflammation than others, likely due to body's response to cold. Price also reads “Aquatic Therapy for Chronic Back Pain”, column by Ed Tobias. =================================== Are you interested in learning more about multiple sclerosis...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Owlytics’ provided scientific evidence that the smartwatch may be used as a measure of response to a treatment in a clinical trial. Plus, reads “Curing Headaches, Pain, and Stress, One Gizmo at a Time”, a column by Jamie Hughes. =================================== Are you interested in learning more about multipl...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses treatment with mesenchymal stem cells or MSCs in adults with active MS failed to significantly reduce brain inflammation, trial data show. Plus, reads the column by John Connor, Fall Down, Get Up Again, “There’s a New Primary Carer in Town”. =================================== Are you interested in learning more abou...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an early MRI measures of brain atrophy and serum NfL levels may accurately predict progression for relapsing forms of MS, a study suggests. Also, Price reads “More Answers About COVID-19 Vaccines and MS”, a column by Ed Tobias. =================================== Are you interested in learning more about multiple scl...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how younger RRMS patients (under 50) whose active disease fails to respond to DMT use might consider a patient-derived bone marrow transplant. Also, Price reads "“Kintsugi Reminds Me That Living With MS Isn’t Something to Hide”", a column by Jamie Hughes. =================================== Are you interested in lear...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Innodem and Novartis Canada are launching a clinical trial to evaluate biomarker eye-tracking technology for monitoring MS progression. Plus, Price reads “My Coffee Cup Runneth Over, Plus a Darned Interruption”, a column by John Connor. =================================== Are you interested in learning more about...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with the anti-malaria medication hydroxychloroquine may help slow disability progression among people with PPMS. Price Wooldridge, reads the column by Jamie Hughes, A Life in Letters, “Just Put One Foot in Front of the Other”. =================================== Are you interested in learning more about...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how people in Australia with multiple sclerosis (MS) and certain other medical conditions will have access to new and expanded medications — including Kesimpta — now listed on the Pharmaceutical Benefits Scheme (PBS). Plus, Price reads the column by Jamie Hughes, A Life in Letters, “Celebrity or Not, You Matter to th...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about how one year of Ocrevus (ocrelizumab) treatment does not increase the risk of a rare brain infection known as PML in people with MS, a study suggests. Plus, Price reads the column by John Connor, Fall Down, Get Up Again, “On the Healing Powers of THC”. =================================== Are you interest...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with evobrutinib reduced the size of inflammation-associated brain lesions in a Phase 2 trial in relapsing multiple sclerosis. Plus, Price reads the column by Jamie Hughes, A Life in Letters, “Being Prepared Can Help Us Succeed”. =================================== Are you interested in learning more ab...

Since 1985 Cyndi Zagieboylo has dedicated her life’s work to achieving National Multiple Sclerosis Society’s vision of a world free of MS. While serving on the Society's National Board of Directors as CEO and president, Cyndi serves on the Multiple Sclerosis International Federation CEO Advisory Group and Board of Trustees. A founding member of the International Progressive MS Alliance launched in...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how deep brain stimulation effectively reduces tremors in people with multiple sclerosis, according to a review study. Plus, Price Wooldridge, reads “Permanent Ink: My Tattoo Serves as an Important Reminder”, a column by Jamie Hughes. =================================== Are you interested in lear...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an article about how increasing the activity of the Myc gene can make myelin-repairing cells more efficient, a finding that may help advance MS treatments, a study says; and reads the column by John Connor, Fall Down, Get Up Again, “I’m Back in the Desert Without a Horse”. =================================== Are you...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Immunic Therapeutics has enrolled a patient in the Phase 2 clinical trial CALLIPER, testing oral IMU-838 for progressive MS; and reads the column by Ed Tobias, MS Wire, “Sun-seeking Finds Support in New Study.” =================================== Are you interested in learning more about multiple sclerosis? If so...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how TG Therapeutics is seeking FDA approval for ublituximab, its anti-CD20 monoclonal antibody infusion therapy for RRMS and SPMS with relapses; and reads the column by Jamie Hughes, A Life in Letters, “Listening to My Body as I Experiment With a New Diet”. =================================== Are you interested in le...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an article about how NervGen will use Imeka's biomarker imaging technology to measure changes in brain and spinal cord in its Phase 1b/2 trials. Plus, Price reads the column by John Connor, Fall Down, Get Up Again, “Party on, Dude, but I’m Still Blaming the Dog!” =================================== Are you interested...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how cognitive rehabilitation is an effective, low-risk and low-cost approach to treating cognitive problems of multiple sclerosis, study found; and reads the column by Ed Tobias, MS Wire, “I’m Back on the MS ‘Bladder Coaster’.” =================================== Are you interested in learning more about multiple scl...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how the first patient who completed GeNeuro’s ProTEct-MS Phase 2 trial has entered the study's extension, which will test higher doses of temelimab. Also, Price reads the column by Jamie Hughes, A Life in Letters, “You Don’t Always Need to Fix It”. =================================== Are you inte...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how mesenchymal stem cells can improve functional abilities and promote the remyelination in rodent models of MS, according to a meta-analysis. Plus, reads a column by John Connor, Fall Down, Get Up Again, “Groundhog Day, Groundhog Day, Groundhog Day, Groundhog Day.” Are you interested in learning more about multiple...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how in an unexpected discovery, scientists found that increasing the activity of PDGFRA reduces the production of myelin in the nervous system; and reads the column by Ed Tobias, MS Wire, “My Lemtrada Treatment, 5 Years Later.” =================================== Are you interested in learning more about multiple scl...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a light-sensing protein present in the brain during fetal development may help explain why MS is more common among people born in spring. Plus, Price reads the column by Jamie Hughes, A Life in Letters, “Making the Most of Both Good Days and Bad”. Are you interested in learning more about multiple sclerosis? If s...